Protocol for a randomized, double blind, placebo controlled, crossover trial of Melatonin for treatment of Nocturia in adults with Multiple Sclerosis (MeNiMS)
Abstract Background Nocturia (the symptom of needing to wake up to pass urine) is common in progressive Multiple Sclerosis (MS) patients. Moderate-to-severe nocturia affects quality of life, can exacerbate fatigue and may affect capacity to carry out daily activities. Melatonin is a natural hormone...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2017-03-01
|
| Schriftenreihe: | BMC Neurology |
| Schlagworte: | |
| Online-Zugang: | http://link.springer.com/article/10.1186/s12883-017-0845-y |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|